1,600 results on '"Masumori, Naoya"'
Search Results
102. Trial evaluating the efficacy and safety of aprepitant, palonosetron and dexamethasone antiemetic therapy (APDATE) for germ cell tumors: results of a single-arm study.
103. Are there differences in the characteristics of patients who respond to gemcitabine plus cisplatin chemotherapy and those who respond to pembrolizumab therapy for metastatic urothelial carcinoma? Multicenter retrospective study
104. Summary of the Clinical Practice Guidelines for Penile Cancer 2021 by the Japanese Urological Association
105. PD02-05 EFFICACY AND SAFETY OF VIBEGRON AS ADJUVANT TREATMENT ON REFRACTORY NEUROGENIC BLADDER DYSFUNCTION IN CHILDREN WITH SPINA BIFIDA
106. 開腹止血術を要したESWLによる腎損傷の一例
107. Prognostic impact of the expression of ALDH1 and SOX2 in urothelial cancer of the upper urinary tract
108. Significance of anaerobic bacteria in postoperative infection after radical cystectomy and urinary diversion or reconstruction
109. Transgenic Mouse Models of Prostate Cancer
110. Additional file 1 of DWI-related texture analysis for prostate cancer: differences in correlation with histological aggressiveness and data repeatability between peripheral and transition zones
111. A Review of Naftopidil for Treatment of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia
112. Gene Expression Profiles of Prostate Cancer Stem Cells Isolated by Aldehyde Dehydrogenase Activity Assay
113. Self‐administration of gender‐affirming hormones and supratherapeutic dosing are relatively common in Japanese transgender women
114. Evaluation of tumor genomic variants in Japanese patients with metastatic castration-sensitive prostate cancer (mCSPC) treated with apalutamide: Protocol of a phase 4 study (CUARTET).
115. Clinical significance of definite muscle layer in TUR specimen for evaluating progression rate in T1G3 bladder cancer: multicenter retrospective study by the Sapporo Medical University Urologic Oncology Consortium (SUOC)
116. 腎盂癌との鑑別が困難であった線維上皮性ポリープの1例
117. 膀胱自然破裂により汎発性腹膜炎を呈した1例
118. 菌血症を呈した尿路感染症の治療経過の検討
119. Durable Response after Discontinuation Due to Immune-Related Adverse Events in a Patient with Metastatic Clear Cell Renal Cell Carcinoma : A Case Report
120. Distinctive Features of Female-to-Male Transsexualism and Prevalence of Gender Identity Disorder in Japan
121. Natural history of benign prostatic hyperplasia
122. Pembrolizumab plus axitinib versus sunitinib in metastatic renal cell carcinoma: outcomes of Japanese patients enrolled in the randomized, phase III, open-label KEYNOTE-426 study
123. Efficacy of vibegron in patients with overactive bladder: Multicenter prospective study of real‐world clinical practice in Japan, SCCOP study 19‐01
124. Outcomes of open partial nephrectomy for renal cell carcinoma in the minimally invasive approach era
125. Metastatic renal epithelioid angiomyolipoma arising after a 23-year follow-up of sporadic renal angiomyolipoma
126. Hypoxia-inducible factor (HIF)-independent expression mechanism and novel function of HIF prolyl hydroxylase-3 in renal cell carcinoma
127. Clinical outcomes of urothelial carcinoma of the prostate detected in radical cystectomy specimens
128. Evaluation of long-term outcome for patients with renal cell carcinoma after surgery: analysis of cancer deaths occurring more than 10 years after initial treatment
129. DNA METHYLATION INHIBITORS MAY REVERSE DRUG-RESISTANCE IN HUMAN BLADDER CANCER CELLS: MP61-10
130. DEVELOPMENT OF A NEW PROGNOSTIC MODEL TO PREDICT SURVIVAL OF PATIENTS WITH METASTATIC UROTHELIAL CARCINOMA RECEIVING FIRST-LINE GEMCITABINE PLUS CISPLATIN CHEMOTHERAPY: MULTICENTER RETROSPECTIVE STUDY BY THE SAPPORO MEDICAL UNIVERSITY UROLOGIC ONCOLOGY CONSORTIUM (SUOC): MP27-06
131. CLINICAL OUTCOMES IN PATIENTS WITH METASTATIC PAPILLARY RENAL CELL CARCINOMA: A JAPANESE MULTI-INSTITUTIONAL STUDY: MP03-13
132. Low serum dehydroepiandrosterone examined by liquid chromatography-tandem mass spectrometry correlates with poor prognosis in hormone-naïve prostate cancer
133. Clinicopathological characteristics of Xp11.2 translocation renal cell carcinoma in adolescents and adults: Diagnosis using immunostaining of transcription factor E3 and fluorescence in situ hybridization analysis
134. Short-term functional and oncological outcomes of partial nephrectomy for renal cell carcinoma in patients with an anatomically or functionally solitary kidney: single-center experience
135. Resection of the inferior vena cava for urological malignancies: single-center experience
136. Identification of a subgroup with worse prognosis among patients with poor-risk testicular germ cell tumor
137. Palonosetron with aprepitant plus dexamethasone to prevent chemotherapy-induced nausea and vomiting during gemcitabine/cisplatin in urothelial cancer patients
138. Decrease in incidence of surgical site infections in contemporary series of patients with radical cystectomy
139. What sexual symptoms are most related to testosterone deficiency among older Japanese men?
140. Tumor-infiltrating CD8+ T cells recognize a heterogeneously expressed functional neoantigen in clear cell renal cell carcinoma
141. THE INCUBATION OF ADULT TESTIS TISSUES BASED ON THE GAS-LIQUID INTERFACE METHOD MAINTAIN GERM CELL WITH TESTICULAR ARCHITECTURE
142. Nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis from male urethritis in Japan: Comparison with the first surveillance report
143. Reduction of susceptibility to azoles and 5-fluorocytosine and growth acceleration in Candida albicans in glucosuria
144. Therapeutic options to reduce intravesical recurrence in newly diagnosed Ta high‐grade bladder cancer according to risk stratification: A multicenter retrospective study
145. CLINICAL OUTCOMES OF GENDER AFFIRMING SURGERY FOR GENDER DYSPHORIA/INCONGRUENCE: A SINGLE-INSTITUTE EXPERIENCE
146. Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
147. Contemporary Patients With LUTS/BPH Requiring Prostatectomy Have Long-term History of Treatment With α1-Blockers and Large Prostates Compared With Past Cases
148. Efficacy and safety of docetaxel and prednisolone for castration-resistant prostate cancer: a multi-institutional retrospective study in Japan
149. Editorial Comment from Dr Masumori to Treatment satisfaction and clinically meaningful symptom improvement in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: Secondary results from a 6-month, randomized, double-blind study comparing finasteride plus tadalafil with finasteride plus placebo
150. Bladder Neck Rupture and Vesicovaginal Fistula Associated with Pelvic Fracture in Female
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.